Improving infection reporting in hematology treatment trials.
作者信息
Teh Benjamin W, Reynolds Gemma K, Mikulska Malgorzata, Mueller Nicolas J, Slavin Monica A
机构信息
Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.
出版信息
Blood Adv. 2024 Nov 26;8(22):5925-5926. doi: 10.1182/bloodadvances.2024013859.
Abstract
摘要
相似文献
1
Improving infection reporting in hematology treatment trials.改善血液学治疗试验中的感染报告。
Blood Adv. 2024 Nov 26;8(22):5925-5926. doi: 10.1182/bloodadvances.2024013859.
2
Evidence of selective reporting bias in hematology journals: A systematic review.血液学杂志中选择性报告偏倚的证据：一项系统评价。
PLoS One. 2017 Jun 1;12(6):e0178379. doi: 10.1371/journal.pone.0178379. eCollection 2017.
3
Hematology journals do not sufficiently adhere to reporting guidelines: a systematic review.血液学期刊未充分遵循报告指南：系统评价。
J Thromb Haemost. 2017 Apr;15(4):608-617. doi: 10.1111/jth.13637. Epub 2017 Feb 27.
4
Evolution of Hematology Clinical Trial Adverse Event Reporting to Improve Care Delivery.血液学临床试验不良事件报告的演变，以改善护理服务。
Curr Hematol Malig Rep. 2021 Apr;16(2):126-131. doi: 10.1007/s11899-021-00627-3. Epub 2021 Mar 30.
5
Assessment of adherence with oral anticancer agents in oncology clinical trials: A systematic review.肿瘤学临床试验中口服抗癌药物依从性的评估：一项系统评价。
J Oncol Pharm Pract. 2016 Feb;22(1):105-13. doi: 10.1177/1078155214567163. Epub 2015 Jan 10.
6
Harmonization of interpretative comments in laboratory hematology reporting: the recommendations of the Working Group on Diagnostic Hematology of the Italian Society of Clinical Chemistry and Clinical Molecular Biology (WGDH-SIBioC).实验室血液学报告中解释性注释的协调：意大利临床化学和临床分子生物学学会诊断血液学工作组（WGDH-SIBioC）的建议。
Clin Chem Lab Med. 2018 Dec 19;57(1):66-77. doi: 10.1515/cclm-2017-0972.
7
Critical values in hematology of 862 institutions in China.中国862家机构血液学的危急值。
Int J Lab Hematol. 2017 Oct;39(5):513-520. doi: 10.1111/ijlh.12681. Epub 2017 May 12.
8
Reporting of race and ethnicity at an international haematology conference.在一次国际血液学会议上对种族和族裔的报告。
Br J Haematol. 2020 Dec;191(5):e107-e109. doi: 10.1111/bjh.17065. Epub 2020 Aug 30.
9
Telemedicine in Malignant and Nonmalignant Hematology: Systematic Review of Pediatric and Adult Studies.恶性血液病和非恶性血液病的远程医疗：儿科和成人研究的系统评价。
JMIR Mhealth Uhealth. 2021 Jul 8;9(7):e29619. doi: 10.2196/29619.
10
The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative.血液学临床试验中整合多样性、公平性和包容性的路线图：美国血液学会倡议。
Blood Adv. 2025 Feb 25;9(4):687-695. doi: 10.1182/bloodadvances.2024013945.
引用本文的文献
1
Noncanonical and mortality-defining toxicities of CAR T cell therapy.嵌合抗原受体T细胞疗法的非典型及决定死亡率的毒性作用
Nat Med. 2025 Jul 16. doi: 10.1038/s41591-025-03813-5.
2
Trapped in the NETs: Multiple Roles of Platelets in the Vascular Complications Associated with Neutrophil Extracellular Traps.被困于中性粒细胞胞外陷阱：血小板在与中性粒细胞胞外陷阱相关的血管并发症中的多重作用
Cells. 2025 Feb 25;14(5):335. doi: 10.3390/cells14050335.
3
Improving reporting of infection events in clinical trials.改善临床试验中感染事件的报告。
Blood Adv. 2024 Nov 26;8(22):5927-5928. doi: 10.1182/bloodadvances.2024014102.
本文引用的文献
1
Proposal for harmonizing the reporting of infections during treatment with bispecific antibodies in multiple myeloma.关于统一多发性骨髓瘤双特异性抗体治疗期间感染报告的提案。
Blood Adv. 2024 Sep 24;8(18):4979-4982. doi: 10.1182/bloodadvances.2024013461.
2
Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis.接受双特异性抗体治疗的淋巴瘤患者的感染：一项系统评价和荟萃分析。
Blood Adv. 2024 Jul 9;8(13):3555-3559. doi: 10.1182/bloodadvances.2024012916.
3
Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients.免疫功能低下患者感染事件报告标准化推进的共识立场声明
Lancet Infect Dis. 2024 Jan;24(1):e59-e68. doi: 10.1016/S1473-3099(23)00377-8. Epub 2023 Sep 6.
4
Infections following bispecific antibodies in myeloma: a systematic review and meta-analysis.多发性骨髓瘤中双特异性抗体相关感染：系统评价和荟萃分析。
Blood Adv. 2023 Oct 10;7(19):5898-5903. doi: 10.1182/bloodadvances.2023010539.
5
Reporting infectious complications in haematology clinical trials should be improved.血液学临床试验中感染性并发症的报告应予以改进。
Clin Microbiol Infect. 2019 Dec;25(12):1451-1453. doi: 10.1016/j.cmi.2019.07.024. Epub 2019 Aug 8.
6
Reporting infections in clinical trials of patients with haematological malignancies.报告血液恶性肿瘤患者临床试验中的感染情况。
Clin Microbiol Infect. 2019 Dec;25(12):1494-1500. doi: 10.1016/j.cmi.2019.04.029. Epub 2019 May 14.
Zotero 插件